Monitor sufferers for respiratory melancholy and sedation at Recurrent intervals. If a CYP3A4 inhibitor is discontinued, take into consideration escalating the PERCOCET dosage until steady drug results are achieved. The chance of suffering from significant withdrawal symptoms is large if a individual is becoming physically dependent and disconti